Kerry has recently made an announcement stating that it has agreed a strategic licensing partnership with Japan’s Pharma Foods International Co. Ltd. (PFI) for the development, application and global sales of a joint health ingredient technology for functional foods and beverages and dietary supplements. Pharma Foods International is a pioneer and leader in innovative ingredients developed from natural food origins for application into functional products, nutraceuticals, cosmetics, and pharmaceuticals.
This partnership and licensing agreement will help Kerry access to the joint health technology developed by PFI through more than a decade of research. The ingredient used by Pharma Foods International will promote the natural production of hyaluronic acid, keeping joints lubricated and mobile and ultimately helping to reduce discomfort and stiffness in knee joints and providing benefit to people with osteoarthritis.
As it is a water-soluble ingredient, it creates opportunities for functional food and beverage applications as well as dietary supplements. The ingredient has already been formulated into several products in the Japanese market and now Kerry will be developing a brand positioning for the technology, supporting application, and development of this product. It will also supply his formulated supplement to customers across the world.